Video

Challenges in Clinical Support for Specialty Therapies

Author(s):

Davy James, Managing Editor

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses the difficulties pharmacies face regarding clinical support for patients starting specialty therapies.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses the difficulties pharmacies face regarding clinical support for patients starting specialty therapies.

Related Videos
Related Content
GLP-1, Ozempic, Diabetes, Weight Loss, Wegovy | Image Credit: © zimmytws | stock.adobe.com
December 24th 2024

RECAP: 2024 Updates in the GLP-1 Space

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

Wooden blocks spelling hemophilia | Image Credit: © lexiconimages - stock.adobe.com
December 23rd 2024

FDA Approves Concizumab-mtci to Prevent, Reduce Bleeding in Patients With Hemophilia A or B

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

FDA Issues Complete Response Letter for Much-Anticipated GLP-2 Analog
December 21st 2024

FDA Issues Complete Response Letter for Much-Anticipated GLP-2 Analog

Aislinn Antrim, Assistant Managing Editor
FDA website homepage -- Image credit: Postmodern Studio | stock.adobe.com
December 21st 2024

FDA Approves Alyftrek, Once-Daily CFTR Modulator for Cystic Fibrosis

Gillian McGovern, Assistant Editor